ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jin, Wook | - |
dc.date.available | 2020-08-24T01:35:18Z | - |
dc.date.created | 2020-08-24 | - |
dc.date.issued | 2020-07 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/78033 | - |
dc.description.abstract | The erythroblastic leukemia viral oncogene homolog (ErBb) family consists of the receptor tyrosine kinases (RTK) epidermal growth factor receptor (EGFR; also called ERBB1), ERBB2, ERBB3, and ERBB4. This family is closely associated with the progression of cholangiocarcinoma (CC) through the regulation of cellular networks, which are enhanced during tumorigenesis, metastasis, and chemoresistance. Additionally, the constitutive activation of cellular signaling by the overexpression and somatic mutation-mediated alterations conferred by the ErBb family on cholangiocarcinoma and other cancers enhances tumor aggressiveness and chemoresistance by contributing to the tumor microenvironment. This review summarizes the recent findings on the molecular functions of the ErBb family and their mutations during the progression of cholangiocarcinoma. It also discusses the developments and applications of various devising strategies for targeting the ErBb family through different inhibitors in various stages of clinical trials, which are essential for improving targeted clinical therapies. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL MEDICINE | - |
dc.title | ErBb Family Proteins in Cholangiocarcinoma and Clinical Implications | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000557225500001 | - |
dc.identifier.doi | 10.3390/jcm9072255 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL MEDICINE, v.9, no.7 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85114282371 | - |
dc.citation.title | JOURNAL OF CLINICAL MEDICINE | - |
dc.citation.volume | 9 | - |
dc.citation.number | 7 | - |
dc.contributor.affiliatedAuthor | Jin, Wook | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | Epidermal growth factor receptor (EGFR) family | - |
dc.subject.keywordAuthor | cholangiocarcinoma | - |
dc.subject.keywordAuthor | aggressiveness | - |
dc.subject.keywordAuthor | mutation | - |
dc.subject.keywordAuthor | chemoresistance | - |
dc.subject.keywordAuthor | EGFR family-targeting inhibitors | - |
dc.subject.keywordPlus | GROWTH-FACTOR RECEPTOR | - |
dc.subject.keywordPlus | MODIFIED T-CELLS | - |
dc.subject.keywordPlus | EPITHELIAL-MESENCHYMAL TRANSITION | - |
dc.subject.keywordPlus | BILIARY-TRACT CANCER | - |
dc.subject.keywordPlus | PHASE-II TRIAL | - |
dc.subject.keywordPlus | INTRAHEPATIC CHOLANGIOCARCINOMA | - |
dc.subject.keywordPlus | BILE-ACIDS | - |
dc.subject.keywordPlus | EXTRAHEPATIC CHOLANGIOCARCINOMA | - |
dc.subject.keywordPlus | C-MET | - |
dc.subject.keywordPlus | TUMOR PROGRESSION | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scie | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.